Diagnosis and Management of Marfan Syndrome (MFS) Throughout the Lifespan
2022
- 102Usage
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Usage102
- Abstract Views51
- Downloads51
Poster Description
This CME presentation aims to highlight the role of the primary care provider in diagnosis and management of Marfan syndrome. Marfan syndrome (MFS) is an autosomal dominant connective tissue disorder that affects many body tissues including blood vessels, eyes, bones, muscles, and ligaments. Pathognomonic findings include aortic root dilation and ectopia lentis. MFS is also often characterized by a constellation of physical manifestations such as arachnodactyly, tall stature, elongated face, flexible joints, and scoliosis. Diagnosis is made using the Modified Ghent Criteria. Primary care providers are responsible for referring the patient to the required specialists. Patients should be treated preventatively with a beta blocker and screened regularly with echocardiograms. Early diagnosis and appropriate management allows the life expectancy of patients with MFS to reach that of the general population.
Bibliographic Details
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know